| DC Field | Value | Language |
|---|
| dc.contributor.author | Kudryavtsev, K. V. | - |
| dc.contributor.author | Korokin, M. V. | - |
| dc.contributor.author | Gudyrev, O. S. | - |
| dc.date.accessioned | 2022-05-04T16:51:16Z | - |
| dc.date.available | 2022-05-04T16:51:16Z | - |
| dc.date.issued | 2017 | - |
| dc.identifier.citation | Kudryavtsev, K.V. Pharmacological efficacy of an inhibitor of arginase-2 KUD975 with L-NAME-induced endothelial dysfunction / K. V. Kudryavtsev, M. V. Korokin, O. S. Gudyrev // Research result. Pharmacology and clinical pharmacology. - 2017. - Vol. 3, № 1.- P. 10-17. - Doi: 10.18413/2500-235X-2017-3-1-10-17. - Refer.: p. 17. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46598 | - |
| dc.description.abstract | The study of endotelio- and cardioprotective activity of finished dosage forms - tablets, film-coated, containing 10 mg of phenolic nature KUD-975, was shown a statistically significant decrease in blood pressure and the coefficient of endothelial dysfunction on the background of simulation L-NAME-induced pathology. In the group of animals treated with KUD975 found a statistically significant increase in the concentrations of stable metabolites of nitric oxide, which in addition to the normalization of vasodilation says about endothelioprotektive action of the compounds studied | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | endothelial dysfunction | ru |
| dc.subject | arginase inhibitors | ru |
| dc.subject | compounds of phenolic nature | ru |
| dc.title | Pharmacological efficacy of an inhibitor of arginase-2 KUD975 with L-NAME-induced endothelial dysfunction | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 3, № 1
|
